Best World to invest in A*Star startup with an eye on stem cell-based products
Nisha Ramchandani
Singapore
BEST World International is investing in A*Star spinoff Celligenics as it seeks to leverage on synergies with its own business in the health and wellness sector.
In a filing with the Singapore Exchange on Monday, it said that it had entered into a share subscription agreement (SSA) with Celligenics.
TRENDING NOW
The retirement advice that worries me the most
Haidilao co-founder’s family buys second bungalow in Cluny Hill for S$85 million
From hawker stall to Enterprise Award winner: How Han Keen Juan scaled the Old Chang Kee empire
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned